2024-2028 年切片检查产业创新与成长机会

Innovations and Growth Opportunities in the Biopsy Industry, 2024-2028

出版日期: 2024年10月09日 | 出版商:

Frost & Sullivan | 英文 63 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

由于准确性、自动化和连接性的进步，探索固态切片检查和呼吸切片检查的最新趋势和新机会

由于技术的进步、不断变化的临床需求以及对更高精确度和更低侵入性的追求，切片检查设备市场的面貌正在改变。

在此背景下，Frost & Sullivan 的分析全面概述了各种切片检查设备，主要关注固态组织切片检查。此外，我们强调一个新兴趋势：呼吸道切片检查。呼吸切片检查是一种非侵入性切片检查方式，有可能彻底改变切片检查设备市场的动态，并展示了患者和医疗保健专业人员如何看待这种方式。新应用的出现和对呼吸切片检查设备的需求增加是由于向精准医学的转变以及肿瘤学之外的应用的扩展。切片检查设备产业的创新正在推动自动化、机器人技术、即时影像处理和人工智慧整合的突破性进步，以提高诊断准确性、降低手术风险并扩大在各个医疗领域的应用。

该分析涵盖固态组织切片检查领域的公共和私人资金筹措、併购、公司与研究机构之间的策略联盟以及专利趋势。我们也涵盖关键产业新兴企业，包括高成长科技产业和创新新兴企业。 Frost & Sullivan 预见了未来的发展，因为该产业将整合其他诊断工具和设备以改善功能。最后，分析讨论了该领域的成长机会以及采取更具前瞻性方法的主要企业。

固态组织切片检查技术的重点是最大限度地减少患者的不适并提高准确性。真空辅助切片检查和粗针穿刺切片等技术变得越来越复杂，针越来越细，影像整合也越来越好。具有即时影像导引的自动切片检查系统越来越受欢迎，以减少错误和手术时间。连接功能可实现平台之间的资料共用，这对于多学科考试非常有用。早期阶段的机器人切片检查系统也被引入，以提高针插入的精确度。对这些创新的投资使相关人员处于快速发展的切片检查市场的最前沿。

固态组织切片检查装置
主要企业的固态组织切片检查设备公司
固态组织切片检查设备主要大学研究机构
智慧固态组织切片检查设备主要企业和新兴企业
切片检查技术及应用
透过先进的整合和创新改进切片检查技术
新兴企业和大学积极开发创新解决方案
切片检查技术重点领域关键阶段企业分布
固态切片检查切片策略伙伴关係
固态组织切片检查领域的重大收购
固态组织切片检查资金筹措生态系统和私人资金
固态组织切片检查资金筹措生态系统和公共资助
固态组织切片检查的着名临床试验
固态组织切片检查装置专利趋势
固态组织切片检查自动化和人工智慧整合的专利趋势
固态组织切片检查装置技术蓝图
固态组织切片检查设备市场的策略建议

新创新呼吸活体组织切片

呼吸活体组织切片装置
呼吸活体组织切片相关人员
呼吸活体组织切片装置专利动态

成长机会宇宙

成长机会一：利用人工智慧进行精准切片检查
成长机会 2：具有连接性和机器人自动化功能的智慧切片检查设备
成长机会 3：用于微创手术的切片检查工具

附录

技术成熟度等级 (TRL)：说明

下一步

成长机会的好处和影响
下一步
免责声明

简介目录

Product Code: DB06

Exploring Recent Developments and Emerging Opportunities in Solid Tissue Biopsy and Breath Biopsy Thanks to Advancements in Precision, Automation, and Connectivity

The biopsy device market's landscape is transforming due to technological advancements, evolving clinical needs, and the push for greater precision and minimally invasive approaches.

In that context, this Frost & Sullivan analysis provides a comprehensive overview of different biopsy devices, with its main focus being solid tissue biopsy. In addition, it covers an emerging trend-breath biopsy, a non-invasive biopsy modality that has the potential to completely change the biopsy device market's dynamics and how the modality is perceived among patients and healthcare professionals. Emerging applications and growing demand for breath biopsy devices are due to a shift toward precision medicine, as well as expanding applications beyond oncology. Innovations in the biopsy devices industry focus on advancing technologies, with breakthroughs in automation, robotics, real-time imaging, and AI integration to improve diagnostic accuracy, reduce procedural risks, and expand applications across various medical fields.

This analysis covers funding-public and private-, mergers and acquisitions, strategic collaborations between players and research institutions, and patent trends in the solid tissue biopsy space. Other topics include key emerging players in the industry, including the high-growth technology segment and innovative start-ups. Frost & Sullivan has projected future developments, as the industry integrates devices with other diagnostic tools to improve functionality. Finally, this analysis discusses growth opportunities and key players working in more forward-looking avenues in the field.

Solid tissue biopsy technologies are focusing on minimizing patient discomfort and improving precision. Techniques such as vacuum-assisted biopsy and core needle biopsy are becoming more refined with smaller gauge needles and better image integration. Automated biopsy systems with real-time imaging guidance are gaining traction, aiming to reduce the margin of error and procedure time. Connectivity features allow data sharing across platforms, aiding in multidisciplinary consultations. Early-stage robotic biopsy systems are being introduced, offering enhanced precision in needle placement. Investing in these innovations can position the stakeholders at the forefront of the rapidly evolving biopsy market.

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Biopsy Devices Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Growth Opportunity Analysis

Scope of Analysis
Segmentation
An Overview of Biopsy Devices

Growth Generator

Growth Drivers
Growth Restraints

Solid Tissue Biopsy Technology Analysis

Solid Tissue Biopsy Devices
Key Players in Solid Tissue Biopsy Devices
Key Academic Players in Solid Tissue Biopsy Devices
Key and Emerging Players in Smart Solid Tissue Biopsy Devices
Biopsy Technologies and Applications
Enhancing Biopsy Procedures through Advanced Integration and Innovation
Emerging Companies and Universities Actively Develop Innovative Solutions
Biopsy Technologies Focus Areas: Distribution of Companies across Key Stages
Strategic Partnerships in the Solid Tissue Biopsy Landscape
Notable Acquisitions in Solid Tissue Biopsy
Funding Ecosystem and Private Funding for Solid Tissue Biopsy
Funding Ecosystem and Public Funding for Solid Tissue Biopsy
Notable Clinical Trials in Solid Tissue Biopsy
Patent Trends in Solid Tissue Biopsy Devices
Patent Trends in Automation and AI Integration in Solid Tissue Biopsy
Solid Tissue Biopsy Devices: A Technology Road Map
Strategic Recommendations for the Solid Tissue Biopsy Devices Market

Emerging Innovations: Breath Biopsy

Breath Biopsy Devices
Stakeholders in Breath Biopsy
Patent Trends in Breath Biopsy Devices

Growth Opportunity Universe

Growth Opportunity 1: AI-powered Precision Biopsy
Growth Opportunity 2: Smart Biopsy Devices with Connectivity and Robotic Automation
Growth Opportunity 3: Nano-biopsy Tools for Minimally Invasive Procedures